|
CH602664A5
(en)
|
1973-06-14 |
1978-07-31 |
Sandoz Ag |
2-Tert. amino-alkylamino-pyrimidine derivs.
|
|
ZA835878B
(en)
*
|
1982-08-23 |
1985-03-27 |
Warner Lambert Co |
Cardiotonic agents
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
DE4425616A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Basf Ag |
Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
US5985884A
(en)
|
1996-07-01 |
1999-11-16 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US6943173B2
(en)
|
2000-07-18 |
2005-09-13 |
Neurogen Corporation |
5-substituted 2-aryl-4-pyrimidinones
|
|
TW200300349A
(en)
|
2001-11-19 |
2003-06-01 |
Sankyo Co |
A 4-oxoqinoline derivative
|
|
WO2003094839A2
(en)
|
2002-05-09 |
2003-11-20 |
Cytokinetics, Inc. |
Pyrimidinone compounds, compositions and methods
|
|
US20050234080A1
(en)
|
2002-05-23 |
2005-10-20 |
Coleman Paul J |
Mitotic kinesin inhibitors
|
|
JP2004339159A
(ja)
|
2003-05-16 |
2004-12-02 |
Sankyo Co Ltd |
４−オキソキノリン誘導体を含有する医薬組成物
|
|
EP1699777B1
(en)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2005041888A2
(en)
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
|
EP1697331A4
(en)
|
2003-12-19 |
2010-08-04 |
Merck Sharp & Dohme |
INHIBITORS OF MITOTIC KINESINE
|
|
US7732613B2
(en)
|
2005-09-14 |
2010-06-08 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
WO2007037543A1
(ja)
|
2005-09-29 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
ビアリールアミド誘導体
|
|
WO2007064797A2
(en)
|
2005-11-30 |
2007-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-met and uses thereof
|
|
WO2007124397A2
(en)
|
2006-04-21 |
2007-11-01 |
Trustees Of Boston University |
Ionic viscoelastics and viscoelastic salts
|
|
JP2007308441A
(ja)
*
|
2006-05-22 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
EP2079707B1
(de)
|
2006-10-10 |
2014-12-03 |
proionic GmbH & Co KG |
Verfahren zur umsetzung von 1,3-hetero-aromatischen 2-carboxylaten mit wasser
|
|
WO2008052861A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
|
|
CL2008000065A1
(es)
|
2007-01-12 |
2008-09-22 |
Smithkline Beecham Corp |
Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia.
|
|
CA2676173A1
(en)
|
2007-02-16 |
2008-08-28 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
US20110253929A1
(en)
|
2008-12-22 |
2011-10-20 |
Basf Se |
Mixtures of hydrophobic and hydrophilic ionic liquids and use thereof in liquid ring compressors
|
|
CA2762680C
(en)
|
2009-05-21 |
2018-04-17 |
Chlorion Pharma, Inc. |
Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
|
|
JP6075621B2
(ja)
|
2010-08-10 |
2017-02-08 |
塩野義製薬株式会社 |
新規複素環誘導体およびそれらを含有する医薬組成物
|
|
JP5990262B2
(ja)
|
2011-05-31 |
2016-09-07 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
ヒドリド−トリシアノ−ボラートアニオンを含む化合物
|
|
CN103597646A
(zh)
|
2011-05-31 |
2014-02-19 |
默克专利股份有限公司 |
电解质组合物
|
|
US20140005181A1
(en)
*
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
|
WO2014004676A1
(en)
|
2012-06-26 |
2014-01-03 |
Ironwood Pharmaceuticals, Inc. |
Use of faah inhibitors as neuroprotective agents in the cns
|
|
DK2897939T3
(en)
*
|
2012-09-21 |
2017-05-08 |
Sanofi Sa |
BENZOIMIDAZOLCARBOXYL ACID AMIDE DERIVATIVES FOR THE TREATMENT OF METABOLIC OR CARDIOVASCULAR DISEASES
|
|
DE102012021452A1
(de)
|
2012-10-31 |
2014-04-30 |
Merck Patent Gmbh |
Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion
|
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
|
WO2014207100A1
(en)
|
2013-06-27 |
2014-12-31 |
Basf Se |
A process for coating paper with cellulose using a solution containing cellulose
|
|
JP6026024B2
(ja)
|
2013-06-27 |
2016-11-16 |
ファイザー・インク |
複素芳香族化合物およびそのドーパミンｄ１リガンドとしての使用
|
|
US20170015871A1
(en)
|
2013-11-29 |
2017-01-19 |
Proionic Gmbh |
Method for curing an adhesive using microwave irradiation
|
|
WO2015184011A2
(en)
|
2014-05-28 |
2015-12-03 |
Sanford-Burnham Medical Research Institute |
Agonists of the apelin receptor and methods of use thereof
|
|
CN106459004B
(zh)
*
|
2014-06-06 |
2020-09-15 |
研究三角协会 |
爱帕琳肽受体(apj)激动剂及其用途
|
|
WO2016074757A1
(de)
|
2014-11-11 |
2016-05-19 |
Merck Patent Gmbh |
Verfahren zur herstellung von mono- und bis(perfluoralkyl)fluorophosphatsalzen und deren säuren
|
|
JP6358639B2
(ja)
|
2015-04-24 |
2018-07-18 |
塩野義製薬株式会社 |
６員複素環誘導体およびそれらを含有する医薬組成物
|
|
CA2985542C
(en)
|
2015-05-20 |
2023-10-10 |
Amgen Inc. |
Triazole agonists of the apj receptor
|
|
RS59220B1
(sr)
|
2015-06-03 |
2019-10-31 |
Bristol Myers Squibb Co |
4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primenu u lečenju kardiovaskularnih poremećaja
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
WO2017091513A1
(en)
|
2015-11-24 |
2017-06-01 |
Daiichi Sankyo Company, Limited |
Novel azole derivatives as apelin receptor agonist
|
|
KR102678264B1
(ko)
|
2015-12-04 |
2024-06-24 |
브리스톨-마이어스 스큅 컴퍼니 |
아펠린 수용체 효능제 및 사용 방법
|
|
JP6948322B2
(ja)
|
2015-12-16 |
2021-10-13 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ａｐｊ受容体のａｐｊアゴニストとしてのヘテロアリールヒドロキシピリミジノン
|
|
JP6716711B2
(ja)
|
2016-03-24 |
2020-07-01 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ａｐｊアゴニストとしての６−ヒドロキシ−４−オキソ−１，４−ジヒドロピリミジン−５−カルボキシアミド
|
|
EP3468952B1
(en)
|
2016-06-14 |
2020-11-25 |
Bristol-Myers Squibb Company |
4-hydroxy-3-sulfonylpyridin-2(1h)-ones as apj receptor agonists
|
|
KR102384668B1
(ko)
|
2016-06-14 |
2022-04-07 |
브리스톨-마이어스 스큅 컴퍼니 |
Apj 효능제로서의 6-히드록시-5-(페닐/헤테로아릴술포닐)피리미딘-4(1h)-온
|
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|